Stay updated on Diarrhea in HER2+ Breast Cancer: Trastuzumab/Neratinib Clinical Trial

Sign up to get notified when there's something new on the Diarrhea in HER2+ Breast Cancer: Trastuzumab/Neratinib Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Diarrhea in HER2+ Breast Cancer: Trastuzumab/Neratinib Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    A new revision entry, v3.5.4, has been added to the history, and the previous v3.5.3 entry has been removed.
    Difference
    0.1%
    Check dated 2026-05-16T09:20:02.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The page’s footer indicates an updated ClinicalTrials.gov interface revision from v3.5.2 to v3.5.3. This reflects a platform/version change rather than a change to the study record details.
    Difference
    0.1%
    Check dated 2026-04-25T06:20:55.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2; Deleted Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-18T03:53:08.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The Record History now includes a new version entry (v3.5.0) and removes the earlier version (v3.4.3).
    Difference
    0.1%
    Check dated 2026-03-20T04:00:00.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    Revision v3.4.3 was added to the history and revision v3.4.2 was removed.
    Difference
    0.1%
    Check dated 2026-03-12T21:33:04.000Z thumbnail image
  8. Check
    98 days ago
    Change Detected
    Summary
    A new revision entry (v3.4.2) was added to the history, and the funding notice banner and the previous revision (v3.4.1) were removed.
    Difference
    0.7%
    Check dated 2026-02-12T02:06:16.000Z thumbnail image

Stay in the know with updates to Diarrhea in HER2+ Breast Cancer: Trastuzumab/Neratinib Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Diarrhea in HER2+ Breast Cancer: Trastuzumab/Neratinib Clinical Trial page.